Avacta Group Plc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Avacta Group Plc with three other
companies in this sector in the United Kingdom:
sales of £3.11 million [US$4.05 million]
of which 100%
Tissue Regenix Group PLC
(£1.57 million [US$2.05 million]
of which 92%
was Wound Care), and
Proteome Sciences PLC
(£2.74 million [US$3.57 million]
Avacta Group Plc reported sales of £2.17 million (US$2.82 million)
July of 2016.
increase of 19.4%
versus 2015, when the company's sales were £1.81 million.
Despite this increase, sales are still
below the level achieved in 2014, when Avacta Group Plc
reported sales of £3.18 million.
Sales of Life Sciences saw an increase
that was more than double the company's growth rate: sales were up
60.4% in 2016, from
£439,000.00 to £704,000.00 .